On this episode we’ll take a walk, literally, with the founder and CEO of Rune Labs, Brian Pepin. Brian previously led electroceuticals development at GSK-backed Galvani, built a glucose-sensing contact lens at Verily, paid dues at Google X Labs, and built brain-computer interfaces at Berkeley.

We discuss how Brian and his team at Rune Labs are trying to become the full-stack source, or the fabric, for neuroscience research. Their platform connects patient brain data to clinicians and researchers to help discover and develop novel diagnostics, devices, and even treatments for patients with various neurological disorder..

Note: When we caught up with our guest, he was on the move so forgive a bit of background and mic noise.

This is the TomorrowScale podcast. Hosted by Justin Briggs.

Rune Labs https://runelabs.io

“The era of brain data – Neurotech after the turning point” Rune Labs Blog

“Oscillotherapeutics – Toward real-time control of pathologic oscillations in the brain” (FrontiersIn Topic)

Follow us on Twitter: http://twitter.com/tomorrowscale

Listen on Your Favorite Podcast App

The TomorrowScale Podcast was created to showcase scientists and entrepreneurs who are building science-based businesses, and to hear stories from the benches and in the trenches of research & development. The views expressed by the host and guests are their own, and the content of this show should not be considered legal, tax, or investing advice. Thanks to our guests for sharing their time and knowledge with us. Thank you for listening. Please science responsibly.

  • On this episode, Ochre Bio co-founders join us to discuss turning discarded organs into a goldmine of biological insight with deep phenotypics that enables the company to pan for fine-grained expression of all the genes across millions of individual cells from different locations across an organ, and connect those signals to specific disease processes within [...]

    Continue reading
  • On this episode we’ll meet Dr. Daniel Levner, co-founder and […]

    Continue reading
  • On this episode we’ll meet Thomas Fleming, Oxford-trained engineer, and […]

    Continue reading
  • On this episode, Ochre Bio co-founders join us to discuss turning discarded organs into a goldmine of biological insight with deep phenotypics that enables the company to pan for fine-grained expression of all the genes across millions of individual cells from different locations across an organ, and connect those signals to specific disease processes within [...]

    Continue reading
  • On this episode we’ll meet Dr. Daniel Levner, co-founder and […]

    Continue reading

Leave A Comment